Fact-checked by Grok 2 weeks ago

Lymphatic system

The lymphatic system is a crucial component of the circulatory and immune systems, comprising a network of lymphatic vessels, lymph nodes, lymphoid organs, and lymph fluid that drains excess interstitial fluid from tissues, returns it to the bloodstream, facilitates immune surveillance, and absorbs dietary fats from the gastrointestinal tract.^[1] This system helps maintain fluid homeostasis by reabsorbing approximately 2 to 3 liters of interstitial fluid daily, preventing edema while transporting antigens, antibodies, and immune cells like lymphocytes to lymph nodes for adaptive immune responses.^[2] Anatomically, the lymphatic system includes blind-ended lymphatic capillaries that collect lymph—a clear, watery fluid containing lymphocytes, proteins, and cellular debris—from interstitial spaces, which then converge into larger collecting vessels equipped with valves to ensure unidirectional flow toward the bloodstream.^[1] Key structures encompass over 450 lymph nodes clustered in regions such as the neck, armpits, groin, chest, and abdomen, which filter lymph and house immune cells including B and T lymphocytes; major lymphoid organs like the spleen, thymus, tonsils, and bone marrow; and principal ducts such as the thoracic duct, which drains lymph from most of the body into the venous circulation at the left subclavian vein junction, and the smaller right lymphatic duct serving the upper right quadrant.^[3]^[1] Physiologically, lymph flow is propelled by intrinsic contractions of lymphatic vessel walls (via smooth muscle and pericytes), external compression from skeletal muscles and respiratory movements, and one-way valves that counteract gravity, ultimately integrating with the cardiovascular system to support overall homeostasis.^[4] Beyond fluid balance and immunity—where lymph nodes act as checkpoints for detecting pathogens and initiating responses—the system plays a metabolic role by absorbing chylomicrons (fat particles) through specialized intestinal lacteals, forming chyle that enters the thoracic duct for systemic distribution.^[4] Dysfunctions, such as lymphatic obstruction leading to lymphedema or impaired immunity increasing infection risk, underscore its indispensable role in health, while its vascular network also serves as a primary route for cancer metastasis.^[1]

Anatomy

Lymph and lymphatic vessels

Lymph is a translucent, yellowish fluid that circulates through the lymphatic system, primarily consisting of water, electrolytes, plasma proteins, lipids, and white blood cells, particularly lymphocytes.^[3] It forms when blood plasma filters out of arterial capillaries into the interstitial spaces due to hydrostatic pressure, creating interstitial fluid that accumulates and is absorbed by lymphatic capillaries to prevent tissue swelling.^[5] In the gastrointestinal tract, lymph known as chyle takes on a milky appearance from emulsified fats absorbed via lacteals.^[1] The protein content of lymph is lower than plasma but includes immunoglobulins and other solutes derived from tissue metabolism, with its composition varying by region—such as higher lipid levels in intestinal lymph.^[6] Lymphatic vessels form a hierarchical network that collects and transports lymph from tissues back to the bloodstream, beginning with blind-ended lymphatic capillaries that originate in nearly all tissues except avascular areas like cartilage, bone marrow, and the central nervous system.^[5] These capillaries feature a single layer of endothelial cells with overlapping edges forming one-way flap valves, anchored by filaments to surrounding extracellular matrix, allowing interstitial fluid, proteins, and cells to enter via paracellular and transcellular routes while preventing backflow.^[6] Diameters range from 10 to 70 μm, with button-like junctions of VE-cadherin and PECAM-1 facilitating selective permeability.^[6] Capillaries converge into precollecting vessels, which transition to larger collecting lymphatic vessels characterized by a continuous endothelial lining, a basement membrane, and an outer layer of smooth muscle cells that enable intrinsic phasic contractions.^[1] These collecting vessels, forming functional units called lymphangions, contain bicuspid valves spaced 0.5 to 2 mm apart to ensure unidirectional flow, with contractions generating pressures up to 20–30 cm H₂O.^[6] Smooth muscle coverage increases with vessel size, and adventitial vasa vasorum support larger trunks.^[6] Lymph flow through these vessels relies on extrinsic factors like skeletal muscle contractions, respiratory movements, and arterial pulsations, combined with intrinsic lymphatic pumping, as there is no central heart-like pump.^[5] Collecting vessels merge into lymphatic trunks that drain specific body regions, ultimately converging into the thoracic duct—which handles about 75% of lymph return from the lower body, left arm, and head via the cisterna chyli—or the smaller right lymphatic duct for the upper right quadrant, both emptying into the venous system at the subclavian-jugular vein junctions.^[1] Daily lymph flow averages approximately 2–3 liters in humans, with a 10-fold reserve capacity to accommodate increased fluid loads and prevent edema.^[2]

Primary lymphoid organs

The primary lymphoid organs, the bone marrow and the thymus, serve as the initial sites for the development and maturation of B and T lymphocytes, respectively, from hematopoietic stem cells. In the bone marrow, pluripotent hematopoietic stem cells differentiate into lymphoid progenitors that give rise to B cells through a series of stages involving gene rearrangements and selection processes. The thymus receives T-cell precursors from the bone marrow and supports their maturation into functional T cells via specialized selection mechanisms. These organs provide unique microenvironments essential for antigen-independent lymphocyte generation.^[7] The bone marrow, located primarily in the red marrow of flat bones such as the skull, vertebrae, ribs, sternum, and pelvis, is the central site for hematopoiesis, including B-cell development. Hematopoietic stem cells reside in this red marrow, supported by stromal cells that provide essential growth factors and adhesion molecules to facilitate B-cell maturation from pro-B to immature B stages. In contrast, the yellow marrow, which is predominantly fatty and less active in hematopoiesis, occupies the medullary cavities of long bones like the femur and tibia, serving mainly as a reserve.^[8]^[9] Within the bone marrow, specialized niches maintain the microenvironment for B-cell development, featuring perivascular reticular cells that express cytokines such as interleukin-7 (IL-7) to promote progenitor proliferation and differentiation. These niches, including endosteal and vascular regions, interact with lymphoid progenitors through adhesion and signaling molecules, while vascular sinuses enable the egress of mature immature B cells into the bloodstream.^[9]^[10] The thymus is a bilobed organ situated in the superior mediastinum, divided into an outer cortex and an inner medulla that guide T-cell maturation. The cortex houses immature double-positive (CD4+ CD8+) thymocytes undergoing early differentiation, whereas the medulla contains single-positive mature T cells and specialized structures like Hassall's corpuscles, which are aggregates of medullary thymic epithelial cells involved in regulatory T-cell development.^[11] Thymic epithelial cells play critical roles in T-cell selection: cortical thymic epithelial cells present self-peptides on major histocompatibility complex molecules to mediate positive selection, ensuring T cells can recognize self-MHC, while medullary thymic epithelial cells facilitate negative selection to eliminate self-reactive clones and promote tolerance.^[12] Age-related changes significantly affect these organs, with the thymus undergoing involution after puberty, characterized by progressive loss of lymphoid tissue and reduced output of naive T cells due to decreased epithelial cell function and increased adiposity. In contrast, the bone marrow maintains its hematopoietic activity throughout life, continuing to produce lymphoid progenitors despite some decline in stem cell efficiency.^[13]

Secondary lymphoid organs

The secondary lymphoid organs, primarily the spleen and lymph nodes, serve as structured sites where mature lymphocytes from primary organs encounter antigens and initiate adaptive immune responses. These encapsulated organs are strategically positioned to filter lymph or blood, facilitating interactions between immune cells. Unlike primary lymphoid organs, which focus on lymphocyte maturation, secondary organs emphasize compartmentalized architecture to support antigen presentation and lymphocyte activation.^[14] The spleen is an encapsulated organ located in the left hypochondrium of the abdomen, positioned inferior and medial to the diaphragm and lateral to the stomach. It is surrounded by a dense fibrous capsule of irregular connective tissue that extends inward as trabeculae, dividing the organ into compartments supported by a reticular connective tissue framework. The spleen consists of two main regions: the white pulp and the red pulp, separated by the marginal zone. The white pulp surrounds central arterioles and includes periarteriolar lymphoid sheaths (PALS) rich in T cells and adjacent B-cell follicles with germinal centers, where follicular dendritic cells provide structural support. The red pulp forms a network of splenic cords (Cords of Billroth) and venous sinusoids populated by macrophages and erythrocytes, enabling blood filtration and clearance of damaged cells. The marginal zone, a transitional area between white and red pulp, contains specialized macrophages and dendritic cells that trap antigens from circulating blood. Splenic circulation involves an open system in the red pulp, where blood from trabecular arteries discharges directly into cords before entering sinusoids, contrasting with closed pathways in other vascular beds; this allows efficient scavenging of pathogens and aged blood cells while lymphocytes enter via the marginal zone.^[15]^[16]^[17] Lymph nodes are bean-shaped, encapsulated structures, typically 1-2 cm in size, distributed throughout the body in clusters along lymphatic vessels, with approximately 600-800 nodes in adults forming chains such as cervical, axillary, inguinal, and mesenteric groups. Each node is enclosed by a dense connective tissue capsule that sends trabeculae inward, creating a supportive framework for internal compartments and facilitating lymph flow. The hilum, a medial indentation, serves as the entry point for afferent lymphatic vessels and arteries and the exit for efferent lymphatic vessels and veins. Internally, lymph enters via the subcapsular (afferent) sinus, percolates through trabecular sinuses, and drains via medullary sinuses to efferent vessels at the hilum. The cortex, the outer layer, contains B-cell follicles with germinal centers for B-cell proliferation and deep paracortical regions densely packed with T cells and high endothelial venules for lymphocyte entry. The medulla, the innermost region adjacent to the hilum, consists of medullary cords housing plasma cells, macrophages, and remaining lymphocytes, along with efferent sinuses for lymph egress. This compartmentalized design ensures sequential filtration and cellular interactions within the node.^[18]^[15]

Tertiary and mucosal lymphoid tissues

Tertiary and mucosal lymphoid tissues encompass diffuse, non-encapsulated aggregates of lymphoid cells primarily located in mucosal surfaces and sites of chronic inflammation, serving as inductive sites for localized immune responses.^[19] Mucosa-associated lymphoid tissue (MALT) represents a key component, comprising organized lymphoid structures adapted for antigen sampling and activation of mucosal immunity across various epithelial barriers.^[19] These tissues facilitate the production of secretory IgA, which neutralizes pathogens at mucosal interfaces without promoting inflammation.^[19] MALT includes several specialized structures, such as the tonsils forming Waldeyer's ring in the nasopharynx and oropharynx, Peyer's patches in the ileum, and the appendix.^[19] Waldeyer's ring consists of the palatine tonsils, adenoids (pharyngeal tonsils), tubal tonsils, and lingual tonsils, strategically positioned at the junctions of the respiratory and digestive tracts to sample airborne and ingested antigens via crypts and lymphoepithelium.^[20] These tonsils process antigens through dendritic cells and macrophages, activating T and B cells to generate IgA and IgG for mucosal defense and memory responses.^[20] Peyer's patches, located in the lamina propria and submucosa of the distal small intestine, function as primary inductive sites for IgA-committed B cells, with antigens from the gut lumen initiating T cell-dependent and independent responses.^[19] The appendix, part of gut-associated lymphoid tissue (GALT) within MALT, contains chains of B cell-rich follicles with germinal centers, follicular dendritic cells, and T cell zones, maturing postnatally to support class-switching to IgA and serving as a reservoir for memory B cells.^[21]^[22] The structure of Peyer's patches features follicle-associated epithelium (FAE) overlying lymphoid follicles, characterized by reduced villi, a thin mucosa, and a porous basal lamina to enhance antigen access.^[23] Within the FAE, microfold cells (M cells) specialize in endocytosis and transcytosis of luminal antigens, delivering them through transcellular pores to underlying antigen-presenting cells like dendritic cells and macrophages for immune activation.^[23]^[24] This mechanism enables efficient surveillance of gut microbiota and pathogens, promoting IgA production by plasma cells in the adjacent lamina propria.^[24] Bronchus-associated lymphoid tissue (BALT) and nasal-associated lymphoid tissue (NALT) provide analogous structures for respiratory and upper airway immunity.^[25] BALT consists of lymphocyte clusters adjacent to major airways, including B cell follicles with germinal centers, surrounding T cell zones, follicular dendritic cells, and high endothelial venules, often forming inducibly (iBALT) in response to infection or inflammation.^[25] It supports local priming of T and B cells, isotype switching to IgA and IgG, and memory maintenance against respiratory pathogens like influenza.^[25] NALT, disseminated in the human nasal mucosa (e.g., middle concha), features lymphoid follicles, lymphoepithelium, and high endothelial venules, acting as an inductive site for IgA responses to inhaled antigens and facilitating nasal vaccination efficacy.^[26] Diffuse lymphoid tissues complement organized MALT by distributing effector cells throughout mucosal layers, including intraepithelial lymphocytes (IEL) and lamina propria populations.^[27] IEL reside between epithelial cells, with approximately one IEL per 10 epithelial cells in the small intestine, comprising mostly TCRαβ+ and TCRγδ+ T cells expressing CD8αα and CD103 for cytotoxicity and barrier maintenance against pathogens.^[27] Lamina propria populations include IgA-producing plasma cells, mature T cells, dendritic cells, and macrophages, dispersed in connective tissue to execute effector functions and regulate tolerance to commensals.^[27] Tertiary lymphoid structures (TLS) arise de novo in non-lymphoid tissues during chronic inflammation, forming ectopic follicles with distinct T/B cell zones, germinal centers, and high endothelial venules to sustain local antigen-specific responses.^[28] In rheumatoid arthritis, TLS develop in synovial tissues, promoting autoantibody production via B cell activation and contributing to disease persistence.^[28] In tumors, TLS form adjacent to malignant cells, enhancing anti-tumor immunity through T cell priming and correlating with improved prognosis in cancers like colorectal carcinoma.^[28]

Development

Embryonic origins

The lymphatic system originates from the venous endothelium during embryonic development. Around the sixth week of gestation, lymphatic endothelial cell (LEC) precursors bud from the anterior cardinal veins, marking the initial specification of the lymphatic lineage. This process is driven by the transcription factors Prox1 and Sox18, which induce LEC fate in a subset of venous endothelial cells, leading to their migration and proliferation to form primitive lymphatic structures.^[29]^[30]^[31] These budding LECs coalesce to form the primary lymph sacs, including the paired jugular lymph sacs near the brachiocephalic veins, the retroperitoneal lymph sac in the mesentery, and the cisterna chyli in the posterior abdomen. Initially, these sacs maintain multiple connections to the venous system for fluid entry, but during further development, most venous communications regress, establishing the lymphatic system's independence from the bloodstream while retaining key junctions like the thoracic duct outlet.^[32]^[33]^[34] Lymphatic vessel patterning proceeds through sprouting angiogenesis from these lymph sacs and veins, guided by signaling cues from surrounding mesenchymal cells. Vascular endothelial growth factor C (VEGF-C), secreted by mesenchymal tissues, binds to VEGFR3 on LECs, promoting polarized sprouting and elongation to form primitive capillaries that extend peripherally in a centrifugal manner. This VEGF-C-dependent mechanism ensures organized network formation, connecting the sacs into a continuous vascular plexus by the eighth week.^[35] The primary lymphoid organs also arise from distinct embryonic primordia. The thymus develops from the ventral endoderm of the third pharyngeal pouch around week 6, where epithelial cells interact with neural crest-derived mesenchyme to form the thymic rudiment. Bone marrow hematopoiesis originates from mesodermal progenitors in the yolk sac during primitive stages (weeks 3-4), transitioning to definitive hematopoietic stem cells generated in the aorta-gonad-mesonephros (AGM) region by week 4-5, which later seed the fetal liver and eventual bone marrow cavities.^[36]^[37]^[38] Disruptions in these embryonic processes can lead to congenital anomalies, such as Milroy disease, an autosomal dominant form of primary lymphedema caused by inactivating mutations in the VEGFR3 gene (FLT4). These mutations impair VEGF-C signaling, resulting in hypoplastic or absent lymphatic vessels from early development, manifesting as bilateral lower limb swelling at birth.^[39]^[40]

Postnatal maturation and lymphangiogenesis

Following birth, the thymus undergoes progressive involution, beginning shortly after infancy and accelerating post-puberty, where thymic epithelial cells decrease and the organ is increasingly replaced by adipose tissue, reducing its overall size by approximately 3% per year through middle age.^[41] This process, known as age-related thymic involution, diminishes the production of naïve T cells but is compensated by enhanced peripheral tolerance mechanisms, such as regulatory T cell activity and homeostatic proliferation, to maintain immune self-tolerance.^[42] Despite these adaptations, chronic involution contributes to a narrowed T-cell repertoire, increasing susceptibility to infections and autoimmunity in later life.^[43] Concurrently, the bone marrow expands postnatally to assume dominance in hematopoiesis, with the shift from fetal liver dependency occurring rapidly after birth; by 3 to 4 weeks of age, adult hematopoietic stem cells (HSCs) largely replace fetal types, supporting lifelong blood cell production.^[44] This transition involves remodeling of the bone marrow niche, where stromal cells, endothelial components, and extracellular matrix dynamically regulate HSC quiescence, self-renewal, and differentiation to sustain steady-state hematopoiesis throughout adulthood.^[45] Niche remodeling adapts to physiological demands, such as stress or inflammation, ensuring balanced output of immune cells including lymphocytes critical to the lymphatic system.^[46] Postnatal lymphangiogenesis, the formation of new lymphatic vessels, primarily occurs through sprouting from existing capillaries, driven by the vascular endothelial growth factor C (VEGF-C) binding to its receptor VEGFR3 on lymphatic endothelial cells, promoting their proliferation and migration.^[47] This pathway is activated in response to stimuli like wound healing, where VEGF-C induces transient lymphatic sprouting alongside angiogenesis to facilitate tissue repair and immune cell clearance; similarly, in inflammation, upregulated VEGF-C/VEGFR3 signaling enhances lymphatic drainage to resolve edema.^[48] In pathological contexts such as tumors, aberrant VEGF-C expression stimulates lymphangiogenesis, enabling metastatic spread, though this process highlights the system's plasticity beyond development.^[47] The lymphatic system's adult plasticity allows regeneration after injury, including surgical resection, where lymphatic vessels regrow via ingrowth from adjacent networks and reconnection of disrupted ends, often supported by growth factors like VEGF-C to restore flow within weeks.^[49] In obesity, lymphatic vessels undergo maladaptive remodeling with increased leakiness and reduced pumping efficiency due to adipose accumulation, but exercise training reverses these changes by enhancing vessel contractility and immune cell trafficking.^[50] Such adaptations underscore the lymphatic vasculature's responsiveness to lifestyle factors, maintaining fluid balance and immune surveillance in dynamic physiological states.^[51] With aging, the lymphatic system exhibits functional decline, including reduced lymph flow due to impaired vessel contractility and valve dysfunction, alongside lymph node atrophy characterized by stromal cell loss and disorganized architecture, which hinders immune cell homing and response coordination. Recent studies as of 2025 have shown that rejuvenating meningeal lymphatic vessels in aged mice improves waste clearance and memory function, highlighting potential therapeutic targets for age-related neurological decline.^[52] These changes contribute to immune senescence by limiting antigen presentation and T-cell activation, exacerbating chronic inflammation and vulnerability to infections in the elderly.^[53] Overall, postnatal maturation balances growth, regeneration, and adaptation against progressive deterioration, ensuring the lymphatic system's role in immunity and homeostasis across the lifespan.^[54]

Physiology

Fluid balance and circulation

The lymphatic system plays a critical role in maintaining fluid homeostasis by collecting and returning interstitial fluid, derived from capillary filtration, back to the bloodstream, thereby preventing the accumulation of excess fluid that could lead to edema. In a typical adult, capillaries filter approximately 20 liters of plasma per day into the interstitial space, with about 17 liters reabsorbed directly into the venous capillaries, leaving roughly 3 liters as interstitial fluid that enters the lymphatic capillaries as lymph. This lymph is transported through the lymphatic vessels and ultimately returned to the systemic circulation primarily via the thoracic duct, which empties into the left subclavian vein at a rate of about 2-4 liters per day, equivalent to roughly 50-100% of the total plasma volume recycled daily.^[2]^[55]^[56] Lymph flow is driven by a combination of intrinsic and extrinsic mechanisms that generate pressure gradients from peripheral tissues toward the central veins, counteracting the natural opposition to flow due to higher central venous pressures. Lymphatic vessels exhibit intrinsic pumping through rhythmic contractions of smooth muscle cells in their walls, forming segmental units called lymphangions that actively propel lymph forward. These contractions are supplemented by extrinsic pumps, including skeletal muscle compression during movement and respiratory movements that create negative intrathoracic pressure to facilitate flow in the thoracic duct. Overall, these dynamics ensure efficient drainage despite low lymphatic pressures, typically ranging from 1-10 mmHg in peripheral vessels to slightly higher in collecting ducts.^[57]^[58]^[59] The regulation of interstitial fluid volume is governed by the Starling principle, which describes the net filtration pressure across capillary walls, with the lymphatic system absorbing the excess fluid not reabsorbed venously to maintain balance. The Starling equation quantifies this as:

J_v = K_f \left[ (P_c - P_i) - \sigma (\pi_c - \pi_i) \right]

where J_v is the fluid movement rate, K_f is the filtration coefficient, P_c and P_i are capillary and interstitial hydrostatic pressures, \sigma is the reflection coefficient, and \pi_c and \pi_i are capillary and interstitial oncotic pressures. Under normal conditions, the slight imbalance favoring filtration at the arterial end of capillaries and reabsorption at the venous end results in a net excess of fluid and proteins in the interstitium, which lymphatics collect to prevent osmotic swelling.^[56]^[60] Minor physiological lymphaticovenous anastomoses, or direct shunts between lymphatic and venous capillaries, exist in certain tissues such as the skin and mucosa, providing a supplementary pathway for fluid drainage when primary lymphatic routes are overwhelmed, though they account for only a small fraction of total lymph flow. Disruptions in lymphatic function, such as obstruction or impaired pumping, lead to edema by altering the balance of Starling forces, causing unchecked accumulation of interstitial fluid and proteins that increase tissue oncotic pressure and further filtration.^[61]^[62]^[63]

Dietary fat absorption

The lymphatic system plays a crucial role in the absorption and transport of dietary fats, particularly through specialized structures in the small intestine known as enteric lacteals. These are blind-ended lymphatic capillaries located within the villi of the intestinal mucosa, designed to uptake lipid-rich particles from enterocytes following the digestion of dietary triglycerides by pancreatic lipases and bile salts in the intestinal lumen.^[1] Once digested, the resulting monoglycerides and free fatty acids are absorbed across the apical membrane of enterocytes via passive diffusion and scavenger receptors, where they are re-esterified into triglycerides inside the cell.^[64] Chylomicrons, the primary vehicles for dietary lipid transport, are assembled within enterocytes primarily in the smooth endoplasmic reticulum, where triglycerides, cholesterol, phospholipids, and apolipoproteins (notably apoB-48) are packaged into large lipoprotein particles with a hydrophobic core. This process prevents the overload of the portal vein with massive lipid loads, which could otherwise disrupt hepatic metabolism; instead, chylomicrons are exocytosed basolaterally into the intercellular space and subsequently enter the lacteals through transcytosis or paracellular routes facilitated by transient opening of endothelial junctions.^[65] The majority of long-chain fatty acids (those with 12 or more carbon atoms) are transported via this lymphatic pathway as chylomicrons, whereas short-chain fatty acids (fewer than 12 carbons) are absorbed directly into the portal bloodstream for rapid hepatic delivery.^[66] From the enteric lacteals, chylomicron-laden lymph drains into larger central lacteals at the villus base and then into collecting vessels that converge on mesenteric lymph nodes, where some immune processing may occur before converging into the cisterna chyli. The cisterna chyli serves as a reservoir, propelling the lipid-rich lymph upward through the thoracic duct to empty into the systemic venous circulation at the subclavian vein junction.^[67] Postprandially, this process results in lipemia, rendering the lymph milky-white (chyle) due to high triglyceride content, with thoracic duct flow rates increasing 3- to 5-fold within hours of a high-fat meal to accommodate the surge in lipid absorption.^[68] Clinically, disruptions to this pathway, such as chylothorax from thoracic duct injury during surgery or trauma, can severely impair dietary fat delivery, leading to malnutrition as long-chain fatty acids accumulate in the pleural space rather than reaching the bloodstream. Management often involves dietary shifts to medium-chain triglycerides, which bypass the lymphatics.^[69]

Immune surveillance and response

The lymphatic system plays a crucial role in immune surveillance by facilitating the transport of antigens from peripheral tissues to lymphoid organs, where they can initiate adaptive immune responses. Dendritic cells, as professional antigen-presenting cells, capture pathogens or antigens in tissues and migrate via afferent lymphatic vessels to draining lymph nodes, carrying processed antigens on their surface to stimulate T cell activation.^[70] In mucosal tissues, microfold (M) cells in the epithelium overlying Peyer's patches and other lymphoid structures sample luminal antigens and pathogens, transcytosing them to underlying immune cells for sampling and response initiation.^[71] This antigen transport mechanism ensures efficient surveillance of potential threats without requiring direct bloodstream exposure, maintaining compartmentalized immunity.^[72] Lymphocyte recirculation is essential for continuous immune monitoring, with naive T and B cells constantly trafficking from the blood into lymph nodes through specialized high endothelial venules (HEVs). These venules express adhesion molecules and chemokines that enable lymphocyte extravasation, guided primarily by the interaction of CCR7 on lymphocytes with CCL19 and CCL21 ligands presented on HEVs.^[73] This chemokine axis promotes homing to the paracortex for T cells and follicles for B cells, allowing naive lymphocytes to scan for antigens presented by resident dendritic cells.^[74] The process supports basal recirculation rates of approximately 10^9 lymphocytes per day in humans, ensuring broad tissue coverage. Within lymph nodes, the adaptive immune response is orchestrated through structured interactions. T cell priming occurs in the paracortex, where antigen-loaded dendritic cells present peptides via MHC class II to naive CD4+ T cells, leading to their activation, proliferation, and differentiation into effector subsets like helper T cells.^[75] Concurrently, B cells in follicles encounter antigens and receive T cell help to form germinal centers, specialized sites for somatic hypermutation and affinity maturation, resulting in high-affinity antibody production by plasma cells.^[76] These compartmentalized reactions amplify specific immunity while minimizing off-target effects.^[77] Immune tolerance is maintained through both central and peripheral mechanisms involving the lymphatic system. Central tolerance eliminates self-reactive lymphocytes during development in the thymus for T cells and bone marrow for B cells, preventing autoreactivity at the source.^[78] Peripherally, lymph nodes contribute to tolerance via stromal cell-mediated editing, where lymphatic endothelial cells and fibroblastic reticular cells present peripheral tissue antigens to induce deletion or anergy of self-reactive T cells entering via HEVs.^[79] This process, often involving Aire-dependent antigen expression, broadens tolerance to extrathymic self-antigens.^[80] Activated effector lymphocytes disseminate from lymph nodes to target sites through efferent lymphatic vessels, re-entering the bloodstream at the thoracic duct for systemic distribution. Effector T cells, such as cytotoxic CD8+ cells, and antibody-secreting plasma cells exit via the medullary sinuses, guided by sphingosine-1-phosphate gradients that promote egress.^[81] This pathway enables rapid deployment to infected or inflamed tissues, completing the immune response cycle while naive cells continue recirculation.^[82]

Clinical significance

Diagnostic imaging and assessment

The lymphatic system, being a network of vessels and nodes that is often invisible on standard imaging due to its low-pressure flow and lack of erythrocytes, requires specialized techniques for visualization and functional assessment. Diagnostic imaging plays a crucial role in evaluating lymphatic structure, drainage patterns, and abnormalities such as obstructions or anomalies, aiding in the diagnosis of conditions like lymphedema and guiding interventions.^[83] Common methods include nuclear medicine, contrast-enhanced radiological, and optical imaging modalities, each offering unique insights into anatomy and physiology.^[84] Lymphoscintigraphy is the gold standard for functional imaging of the lymphatic system, involving the subcutaneous or intradermal injection of a low-dose radiotracer, such as technetium-99m sulfur colloid, followed by gamma camera detection to map lymph flow and drainage pathways.^[84] This technique visualizes lymphatic channels and nodes in real-time, identifying asymmetries, delays, or blockages in drainage, which is particularly valuable for staging primary and secondary lymphedema by classifying patterns of transport impairment.^[85] Dynamic imaging during the procedure allows quantification of transit times and collateral vessel formation, with protocols recommending multiple views (e.g., anterior, posterior, and oblique) over 30-90 minutes post-injection for comprehensive evaluation.^[86] Magnetic resonance imaging (MRI) and computed tomography (CT) lymphangiography provide high-resolution anatomical detail of lymphatic vessels and nodes through contrast enhancement, often using gadolinium-based agents for MRI or iodinated contrast for CT.^[83] In MRI lymphangiography, non-invasive pedal or intranodal injection of dilute gadolinium enables T2-weighted and post-contrast T1-weighted sequences to delineate central lymphatic structures like the thoracic duct, detecting leaks, malformations, or obstructions with submillimeter resolution.^[87] CT lymphangiography complements this by offering faster acquisition and better bone/soft tissue contrast, useful for identifying peripheral vessel anomalies or postoperative changes, though it involves ionizing radiation and is typically reserved for cases where MRI is contraindicated.^[88] Both modalities excel in pre-procedural planning for lymphatic interventions, with MRI preferred for its multiplanar capabilities and lack of radiation.^[83] Indocyanine green (ICG) fluorescence lymphography utilizes near-infrared imaging to provide real-time visualization of superficial lymphatic vessels during intraoperative or bedside assessments.^[89] After intradermal or subcutaneous injection of ICG, a fluorescent dye that binds to albumin and is taken up by lymphatics, excitation with near-infrared light (around 800 nm) allows detection of flow dynamics using specialized cameras, highlighting vessel patency, leaks, or dermal backflow patterns indicative of lymphatic dysfunction.^[90] This technique is particularly advantageous for guiding lymphaticovenular anastomosis or node transfers in reconstructive surgery, offering immediate feedback on vessel mapping with depths up to 1-2 cm and minimal invasiveness compared to radiotracer methods.^[89] Ultrasound with Doppler enhancement serves as an accessible, non-invasive tool for initial assessment of peripheral lymph nodes and superficial vessels, combining B-mode grayscale imaging with color or power Doppler to evaluate size, shape, echogenicity, and vascularity.^[91] In B-mode, nodes appear as hypoechoic ovoid structures with a hyperechoic hilum; Doppler assesses hilar versus peripheral blood flow patterns, where avascular or chaotic flow may suggest malignancy or inflammation.^[92] High-frequency transducers (7-15 MHz) enable fine detail for biopsy guidance, with sensitivity for detecting enlarged nodes exceeding 90% in accessible regions like the neck or groin, though it is limited for deep central lymphatics.^[93] Applications of positron emission tomography-computed tomography (PET-CT) focus on functional imaging of lymph nodes in oncology, using tracers like 18F-fluorodeoxyglucose (FDG) to highlight metabolic activity in malignant or reactive nodes.^[94] This hybrid modality integrates PET's sensitivity for detecting hypermetabolic lesions (e.g., SUVmax thresholds >2.5 for suspicion) with CT's anatomical localization, improving staging accuracy for lymphomas and solid tumors by identifying occult nodal metastases not visible on conventional imaging.^[95] In lymphatic assessment, PET-CT excels in monitoring treatment response through interim scans, showing reduced uptake in responding nodes, and is increasingly used for sentinel node evaluation in breast and melanoma cases.^[96]

Lymphatic disorders and lymphedema

Lymphatic disorders encompass a range of conditions that impair the function of the lymphatic system, leading to inadequate fluid drainage and accumulation of lymph in tissues. Lymphedema, the hallmark manifestation, results from congenital or acquired disruptions in lymphatic transport, causing swelling primarily in the limbs. These disorders can be broadly classified as primary, arising from genetic abnormalities, or secondary, due to external damage or obstruction.^[97] Primary lymphedema stems from inherent developmental defects in the lymphatic vasculature, often involving hypoplastic or absent vessels. It is typically genetic in origin and manifests at predictable life stages. Milroy disease, for instance, is an autosomal dominant condition caused by heterozygous pathogenic variants in the FLT4 gene, which encodes vascular endothelial growth factor receptor 3 (VEGFR3); these mutations disrupt lymphatic valve formation and lead to congenital-onset lower-limb swelling at birth or shortly thereafter.^[98] Meige disease, or lymphedema praecox, similarly arises from underdeveloped lymph nodes and channels, often linked to genetic variations, and presents between puberty and the mid-20s with gradual swelling in the feet, ankles, and legs.^[99] A rarer form, lymphedema tarda, may emerge later in life due to progressive lymphatic insufficiency from similar hypoplastic changes.^[100] Secondary lymphedema develops following damage to otherwise normal lymphatic structures and is far more common in clinical practice. Key causes include surgical interventions such as mastectomy with axillary lymph node dissection, which removes or injures lymphatic channels, and radiation therapy, which induces fibrosis and scarring of lymph nodes, impairing fluid filtration and increasing proximal pressure.^[101] Infections also contribute, particularly in endemic regions, by causing chronic inflammation and lymphatic blockade.^[97] The condition progresses through three stages: Stage I features reversible pitting edema that subsides with elevation; Stage II involves spontaneous irreversibility with fibrosis and skin thickening, where pitting may persist but elevation offers little relief; and Stage III, known as lymphostatic elephantiasis, presents non-pitting edema, severe fibrosis, and dermal changes like papillomas.^[97] Lymphatic filariasis represents a major infectious cause of secondary lymphedema, predominantly in tropical areas. It is transmitted via mosquito bites carrying the filarial nematode Wuchereria bancrofti, which invades lymphatic vessels, provoking repeated inflammatory responses. Over years, this chronic inflammation leads to lymphatic dilation, valve incompetence, and eventual elephantiasis—marked by massive limb enlargement from fibrosis and tissue hypertrophy.^[102] Management of lymphatic disorders prioritizes non-invasive strategies to alleviate symptoms and prevent progression. Complete decongestive therapy (CDT) serves as the cornerstone, comprising two phases: an intensive reduction stage with manual lymphatic drainage—a gentle massage technique to redirect fluid—and multilayer compression bandaging to maintain volume reduction, followed by a maintenance phase using custom-fitted garments and self-care education.^[103] For advanced cases unresponsive to CDT, surgical interventions like lymphovenous bypass offer targeted relief by anastomosing functional lymphatic vessels to nearby veins, bypassing obstructions and achieving up to 42% limb volume reduction in early-stage patients.^[103]^[104] Complications of untreated or poorly managed lymphedema significantly impact quality of life. The protein-rich nature of accumulated lymph fosters bacterial growth, predisposing affected tissues to recurrent cellulitis, characterized by acute redness, warmth, and pain requiring prompt antibiotic intervention.^[105] Over time, this stagnant fluid triggers progressive tissue remodeling, including fibrosis, skin hardening, hyperkeratosis, and fat deposition, culminating in irreversible structural changes that exacerbate functional impairment.^[97]

Role in cancer and metastasis

The lymphatic system plays a critical role in cancer progression by facilitating the initial spread of tumor cells from primary sites to regional lymph nodes, a process known as lymphatic metastasis. In approximately 80% of solid tumors, metastasis occurs first via the lymphatic system before involving the bloodstream. Tumor cells invade lymphatic vessels through a mechanism involving lymphangiogenesis, where malignant cells or associated stromal elements secrete vascular endothelial growth factor C (VEGF-C), which binds to VEGFR-3 receptors on lymphatic endothelial cells to promote new vessel formation and expansion. This VEGF-C-driven process enhances vessel permeability and density around the tumor, allowing easier intravasation of cancer cells into the lymphatic circulation. The first drainage site, or sentinel lymph node, serves as a primary predictor of further metastatic spread, as tumor cells typically lodge there before disseminating to distant organs. The sentinel lymph node biopsy (SLNB) is a key diagnostic procedure that identifies the first lymph node(s) receiving drainage from a tumor, guiding cancer staging and treatment decisions. Performed using blue dye, radioisotopes, or both to trace lymphatic flow, SLNB is standard for staging early-stage breast cancer and melanoma, reducing the need for more invasive axillary lymph node dissection. In breast cancer, the status of axillary sentinel nodes determines the N-stage in the TNM classification system, where N0 indicates no regional lymph node metastasis, N1 involves 1-3 nodes, and higher stages reflect greater involvement; this nodal status is one of the strongest prognostic factors for recurrence and survival. For micrometastases—small clusters of tumor cells less than 2 mm—immunohistochemistry (IHC) staining enhances detection in sentinel nodes, though its impact on prognosis remains debated, with some studies showing association with poorer outcomes while others find limited influence on survival. Therapeutic strategies increasingly target the lymphatic system's role in metastasis to improve outcomes. Anti-VEGF agents, such as bevacizumab, inhibit VEGF-C signaling to suppress tumor-induced lymphangiogenesis, potentially reducing nodal metastasis in cancers like colorectal and breast. In immunotherapy contexts, blocking lymphatic drainage—through agents that modulate lymphatic vessel function—can enhance anti-tumor immune responses by preventing immunosuppressive signals from draining lymph nodes and promoting T-cell activation. These approaches are particularly relevant for common lymphatic-metastasizing cancers, including breast (where up to 40% present with nodal involvement at diagnosis), melanoma (with sentinel node positivity in 15-20% of intermediate-thickness cases), and colorectal (where mesenteric nodes are frequent first sites of spread). The lymphatic system plays a critical role in immune defense, but it is frequently targeted by infectious agents, leading to conditions such as lymphadenitis and lymphangitis that disrupt normal lymph flow and immune surveillance. Bacterial infections often initiate acute inflammation in lymphatic vessels and nodes, while viral and parasitic pathogens can cause chronic or systemic involvement, exacerbating immune dysregulation. In autoimmune diseases and immunodeficiencies, lymphatic structures are altered, impairing their function and increasing susceptibility to secondary infections. Bacterial infections commonly affect the lymphatic system by causing lymphadenitis, an inflammation of lymph nodes often resulting from direct microbial invasion or spread from adjacent tissues. A representative example is cat-scratch disease, caused by the bacterium Bartonella henselae, which typically follows a scratch or bite from an infected cat and leads to regional lymphadenopathy with fever and malaise.^[106] The infection triggers granulomatous inflammation within the nodes, and while most cases resolve spontaneously, severe manifestations can involve suppuration or systemic dissemination in immunocompromised individuals.^[106] Lymphangitis, another bacterial complication, involves acute inflammation of lymphatic vessels, most frequently due to Streptococcus pyogenes or Staphylococcus aureus entering through skin breaches, and is characterized by erythematous streaks extending from the infection site toward regional nodes, signaling rapid proximal spread. These streaks, often accompanied by fever and chills, indicate lymphatic obstruction and potential progression to sepsis if untreated.^[107] Viral infections can profoundly impact lymphatic tissues by inducing hyperplasia or depletion of immune cells within nodes. Infectious mononucleosis, primarily caused by Epstein-Barr virus (EBV), results in prominent lymph node enlargement, particularly in the cervical and posterior chains, due to B-cell proliferation and T-cell response, often with associated fatigue, pharyngitis, and splenomegaly.^[108] In chronic cases, EBV can persist in lymphoid tissues, contributing to prolonged nodal reactivity. Human immunodeficiency virus (HIV) infection, conversely, drives progressive CD4+ T-cell depletion in lymph nodes, the primary sites of viral replication, leading to architectural disruption and follicular involution that underlies acquired immunodeficiency.^[109] This depletion, occurring through direct cytopathic effects and immune activation-induced apoptosis, correlates with declining peripheral CD4 counts and increased opportunistic infection risk.^[109] Parasitic infections extend beyond filariasis to involve lymphatic structures in other ways, with toxoplasmosis serving as a key example. Caused by the protozoan Toxoplasma gondii, acquired via contaminated food or cat feces, toxoplasmosis often presents with painless cervical lymphadenopathy in immunocompetent hosts, reflecting tachyzoite dissemination and reactive follicular hyperplasia in nodes.^[110] The infection elicits a robust CD8+ T-cell response in lymphoid tissues, but in immunocompromised individuals, it can reactivate, causing disseminated disease with nodal necrosis.^[111] Autoimmune conditions disrupt lymphatic function through chronic inflammation and aberrant lymphoid organization. In Sjögren's syndrome, an autoimmune disorder targeting exocrine glands, patients face a markedly elevated risk of mucosa-associated lymphoid tissue (MALT) lymphoma, estimated at 44 times higher than the general population, arising from persistent B-cell stimulation in salivary and lacrimal glands' lymphoid aggregates.^[112] This risk stems from chronic antigenic drive and genetic factors like BAFF overexpression, leading to lymphoproliferative transformation. In rheumatoid arthritis, tertiary lymphoid structures (TLS) form ectopically in synovial tissues, mimicking lymph node architecture with segregated T- and B-cell zones, high endothelial venules, and follicular dendritic cells, which perpetuate autoantibody production and joint inflammation.^[113] These TLS, driven by cytokines like lymphotoxin, correlate with disease severity and erosive progression.^[113] Immunodeficiency states highlight the lymphatic system's vulnerability, particularly involving thymic and nodal development. Severe combined immunodeficiency (SCID) features an absent or dysplastic thymus, resulting in profound T-cell deficiency and impaired lymph node maturation, rendering infants susceptible to life-threatening infections from early life.^[114] Genetic defects in recombination-activating genes or IL-2 receptor components underlie this, with lymphoid tissues showing depleted cortical thymocytes and absent Hassall's corpuscles on histology.^[114] DiGeorge syndrome, caused by 22q11.2 deletion, manifests with thymic hypoplasia of varying degrees, leading to partial T-cell lymphopenia and recurrent infections, as the underdeveloped thymus fails to support adequate T-cell education.^[115] The extent of hypoplasia determines immunodeficiency severity, with complete athymia causing SCID-like presentations in severe cases.^[115]

History

Key discoveries and anatomists

The earliest references to components of the lymphatic system appear in ancient Greek and Roman medical texts. Hippocrates (c. 460–377 BC) described vessels carrying a milky fluid, which he called "white veins" or "white blood," distinguishing them from the red blood vessels and associating them with chyle, a term derived from the Greek for juice. Galen (c. 129–c. 216 AD), building on Hippocratic ideas, elaborated on the mesenteric lymph nodes and the transport of chyle through these vessels, proposing a nutritional role where chyle from the intestines was conveyed to the liver for processing into blood.^[116] These observations, though rudimentary and based on dissection and humoral theory, laid the groundwork for later anatomical studies by identifying lymphatic elements as separate from the bloodstream. The 17th century marked a pivotal era in lymphatic discovery, driven by experimental anatomy during the Renaissance. In 1622, Italian anatomist Gaspare Aselli (c. 1581–1625) serendipitously observed numerous white, thread-like vessels in the mesentery of a living, milk-fed dog during a vivisection, terming them "lacteals" due to their milky appearance when filled with chyle; his findings were published posthumously in 1627 in De lactibus sive lacteis venis.^[117] This challenged Galen's view that chyle reached the liver via the portal vein, instead suggesting a direct intestinal pathway. Building on Aselli's work, French anatomist Jean Pecquet (1622–1674) in 1651 demonstrated the continuity of the lacteals with a larger reservoir, the cisterna chyli (which he called the receptaculum chyli), and the thoracic duct, which empties chyle into the venous system at the subclavian vein junction.^[66] Pecquet's experiments with ligatures and injections in animals refuted earlier misconceptions and established the lymphatic system's role in fat absorption and circulation. In the 19th century, advances shifted toward functional and pathological insights. German pathologist Rudolf Virchow (1821–1902) connected lymphatic fluid to immunity through his cellular pathology framework, observing that lymph nodes filter pathogens and that leukocytes in lymph contribute to inflammatory and immune responses, as detailed in his 1858 work Die Cellularpathologie. This integrated lymphatics into broader theories of disease, emphasizing their role beyond mere fluid transport. Early 20th-century histology further refined understanding of lymphatic-associated organs; in 1905, Swedish anatomist Johan August Hammar provided a comprehensive description of the thymus gland's structure, highlighting its epithelial reticulum, Hassall's corpuscles, and thymic vesicles as key to lymphoid development.^[118] The mid-20th century introduced diagnostic innovations. British surgeon John B. Kinmonth (1916–2010) pioneered direct lymphangiography in the 1950s, developing a technique to inject contrast into lower limb lymphatic vessels during surgery, enabling radiographic visualization of lymphatic anatomy and pathology for the first time in living humans; his 1954 paper outlined its clinical application for conditions like lymphedema.^[119] Concurrently, immunological research advanced with the identification of lymphokines in the late 1960s—soluble mediators secreted by activated lymphocytes that regulate immune cell migration and function; the term was coined by Dumonde et al. in their 1969 study demonstrating migration inhibition factor production by sensitized lymphocytes in vitro.^[120] Molecular discoveries in the 1990s revolutionized lymphatic research by identifying specific markers and regulators. Banerji et al. (1999) cloned and characterized LYVE-1 (lymphatic vessel endothelial hyaluronan receptor-1), a CD44 homolog expressed selectively on lymphatic endothelial cells, serving as the first reliable molecular marker for distinguishing lymphatics from blood vessels and facilitating studies of hyaluronan transport.^[121] Similarly, Joukov et al. (1996) discovered vascular endothelial growth factor C (VEGF-C) as a ligand for the tyrosine kinase receptor VEGFR-3 (Flt4), demonstrating its potent induction of lymphatic endothelial proliferation and vessel sprouting, thus establishing VEGF-C as a central driver of lymphangiogenesis.^[122] These findings shifted focus to genetic and signaling mechanisms, enabling targeted research into lymphatic development and disease. In the 2000s and beyond, further milestones included the identification of Prox1 as a master transcription factor for lymphatic endothelial specification (Wigle and Oliver, 1999), with ongoing research as of 2025 exploring lymphatic roles in metabolic disorders, inflammation, and cancer immunotherapy.^[123]

Etymology and nomenclature evolution

The term "lymphatic" derives from the Latin adjective lymphaticus, meaning "stricken with nymph-like anger" or "gripped by madness," which itself stems from lympha, referring to clear water and borrowed from the Greek nymphe (nymph), evoking the limpid appearance of the fluid in these vessels.^[124] In 1654, Danish anatomist Thomas Bartholin introduced the specific term vasa lymphatica to describe the milky vessels he observed during dissection, marking the first precise nomenclature for the peripheral lymphatic system and distinguishing it from previously known vascular structures.^[125] The word "chyle," used to denote the milky lymph formed in the gut from digested fats, originates from the ancient Greek chylos, meaning "juice" or "sap," reflecting its fluid, nutrient-rich nature.^[126] This term, first applied in anatomical contexts by early modern scholars to differentiate intestinal lymph from clearer systemic lymph, has persisted in medical usage to highlight the lymphatic system's role in lipid absorption. Early nomenclature for lymph nodes evolved from the 17th- and 18th-century descriptor "conglobate glands," which emphasized their clustered, glandular appearance and presumed secretory function, as noted in anatomical texts of the period.^[125] By the 19th century, the term shifted to "lymph nodes" or the Greek-derived "lymphaden," combining lympha with adēn (gland), providing a more standardized and etymologically precise label that aligned with emerging understandings of their role in fluid filtration and immunity. Related lymphoid organs also bear etymological roots tied to ancient observations. The thymus gland's name comes from the Greek thymos, denoting a "warty excrescence" due to its lobulated shape, though it was sometimes linked to thymos as "soul" or "spirit" in classical philosophy, reflecting its central thoracic position.^[127] Similarly, the spleen derives from the Greek splēn, simply meaning "spleen" or "milt," and was historically associated with melancholy in humoral theory owing to its proximity to the stomach and perceived influence on temperament via black bile.^[128] In the molecular era following the 1990s, lymphatic terminology expanded with terms like "lymphangiogenesis," coined to describe the sprouting of new lymphatic vessels analogous to angiogenesis, driven by discoveries such as vascular endothelial growth factor C (VEGF-C) in 1996.^[129] Concurrently, outdated phrases like "lymphatic leukemia" from 19th-century classifications—initially used by Rudolf Virchow in 1856 to describe what he termed "lymphatic" forms of chronic leukemia—have been refined to distinguish precise lymphomas, neoplasms of lymphoid tissues, from true leukemias originating in bone marrow.^[130]^[131]

References

[1]
Anatomy, Lymphatic System - StatPearls - NCBI Bookshelf - NIH
Mar 6, 2023 · Components of the lymphatic system include lymph, lymphatic vessels and plexuses, lymph nodes, lymphatic cells, and a variety of lymphoid organs.Introduction · Function · Clinical Significance · Other Issues
[2]
Physiology, Lymphatic System - StatPearls - NCBI Bookshelf
The lymphatic system is an important and often underappreciated component of the circulatory, immune, and metabolic systems.
[3]
Lymph system: MedlinePlus Medical Encyclopedia
### Overview of the Lymph System
[4]
Components of the Lymphatic System - SEER Training Modules
Lymph. Lymph is a fluid similar in composition to blood plasma. It is derived from blood plasma as fluids pass through capillary walls at the arterial end. As ...Lymph Nodes · Spleen · Tonsils · Thymus
[5]
Lymphatic Vessel Network Structure and Physiology - PMC
Lymphatic vessels maintain normal tissue fluid volumes by returning the capillary ultrafiltrate and extravasated plasma proteins to the central circulation.
[6]
Introduction to T and B lymphocytes - Autoimmunity - NCBI Bookshelf
The process of development and maturation of the T Cells in mammals begins with the haematopoietic stem cells (HSC) in the fetal liver and later in the bone ...
[7]
Structural organization of the bone marrow and its role in ...
The bone marrow is the main site for hematopoiesis. It contains a unique microenvironment that provides niches that support self-renewal and differentiation ...
[8]
Generation of lymphocytes in bone marrow and thymus - NCBI - NIH
The early stages of B-cell development are dependent on bone marrow stromal cells. The upper panels show the interactions between precursor B cells and stromal ...
[9]
Bone Marrow Vascular Niche: Home for Hematopoietic Stem Cells
Vascular niche has been regarded as an alternative indispensable niche operating regulation on hematopoietic stem cells (HSCs).
[10]
Thymic Crosstalk Coordinates Medulla Organization and T-Cell ...
The cortex supports early stages of T-cell differentiation, including the positive selection of CD4+ and CD8+ thymocytes.
[11]
Thymic stromal cell subsets for T cell development - PubMed Central
The thymus is subdivided into two histologically discrete regions, the cortex and medulla. The cortex is the outer region of the thymus, where a stromal ...
[12]
The Effect of Age on Thymic Function - PMC - NIH
Oct 7, 2013 · Age-related involution is associated with reduced thymic mass and altered architecture resulting in reduced thymic output in the aged thymus. In ...
[13]
In brief: What are the organs of the immune system? - NCBI - NIH
Aug 14, 2023 · Secondary lymphoid organs: These organs include the lymph nodes, the spleen, the tonsils and certain tissue in various mucous membrane layers ...
[14]
https://www.ncbi.nlm.nih.gov/books/NBK279395/
[15]
Physiology, Spleen - StatPearls - NCBI Bookshelf - NIH
May 1, 2023 · White pulp throughout the spleen is surrounded by red pulp. The red pulp is composed of splenic cords (Cords of Billroth) and a large volume ...Cellular Level · Function · Related Testing · Pathophysiology
[16]
Tolerance and Lymphoid Organ Structure and Function - Frontiers
Dec 6, 2011 · The spleen is surrounded by a capsule that extends many projections into the interior to form a compartmentalized structure (Figures 1A,B).
[17]
Anatomy, Lymph Nodes - StatPearls - NCBI Bookshelf - NIH
Jul 25, 2023 · The lymphatic system is composed of lymphatic vessels and lymphoid organs such as the thymus, tonsils, lymph nodes, and spleen.
[18]
The mucosal immune system - Immunobiology - NCBI Bookshelf - NIH
The mucosa-associated lymphoid tissues lining the gut are known as gut-associated lymphoid tissue or GALT. The tonsils and adenoids form a ring, known as ...
[19]
Anatomy and physiology of the palatine tonsils, adenoids, and ... - NIH
Waldeyer's ring consists of non-contiguous mucosal-associated lymphoid tissues (MALT) arranged in a circumferential configuration in the nasopharynx and ...
[20]
Human gut-associated lymphoid tissues (GALT); diversity, structure ...
Mar 22, 2021 · Gut-associated lymphoid tissues (GALT) are the key antigen sampling and adaptive immune inductive sites within the intestinal wall.Review-Article · Peyer's Patches · Isolated Lymphoid Follicles
[21]
Anatomical Uniqueness of the Mucosal Immune System (GALT ...
Of course, one of the main functions of MALT in the gut, including ILFs, Peyer's patches, cecal patches, and colonic patches, is the production of IgA in ...
[22]
Peyer Patches - StatPearls - NCBI Bookshelf - NIH
Jan 2, 2023 · Peyer patches are a group of well-organized lymphoid follicles located in the lamina propria and submucosa of the distal portion of the small intestine.Missing: components tonsils appendix
[23]
Roles of M cells in infection and mucosal vaccines - PMC - NIH
M cells are capable of transporting luminal antigens to the underlying lymphoid tissues and can be exploited by pathogens as an entry portal to invade the host.
[24]
Bronchus-Associated Lymphoid Tissue (BALT): Structure and Function
BALT is a constitutive mucosal lymphoid tissue adjacent to major airways in some mammalian species, including rats and rabbits, but not humans or mice.
[25]
Nasal-associated lymphoid tissue (NALT) - PubMed Central - NIH
NALT as defined in the present study means the presence of organized lymphoid tissue in the nasal mucosa with aggregates of lymphocyte like follicles and ...
[26]
Intestinal Intraepithelial Lymphocytes: Sentinels of the Mucosal Barrier
Apr 20, 2021 · IEL are a large and diverse population of lymphoid cells that reside between the intestinal epithelial cells (IEC) that form the intestinal mucosal barrier.
[27]
The roles of tertiary lymphoid structures in chronic diseases - PMC
Apr 12, 2023 · Tertiary lymphoid structures (TLSs) are ectopic lymphoid tissues that drive antigen-specific immune responses at sites of chronic inflammation.
[28]
Sox18 induces development of the lymphatic vasculature in mice
Dec 4, 2008 · Sox18 is expressed in a subset of cardinal vein cells that later co-express Prox1 and migrate to form lymphatic vessels. Sox18 directly ...
[29]
Lymphatic endothelial progenitors bud from the cardinal vein and ...
We have previously shown that the embryonic veins are the unique source of the entire mammalian lymphatic vasculature by showing that Prox1-expressing LECs ...
[30]
Endothelial ERK signaling controls lymphatic fate specification - JCI
Feb 8, 2013 · Lymphatic vessels are thought to arise from PROX1-positive endothelial cells (ECs) in the cardinal vein in response to induction of SOX18 ...
[31]
Anatomy, Thorax, Thoracic Duct - StatPearls - NCBI Bookshelf
Six lymph sacs form by the end of the embryonic period. These lymph sacs are the cisterna chyli, two jugular lymph sacs, two iliac lymph sacs, and a ...Missing: regression | Show results with:regression
[32]
Biological Basis of Therapeutic Lymphangiogenesis | Circulation
Mar 29, 2011 · After formation of the primary lymph sacs along the anteroposterior embryonic ... venous connections. Indeed, work in nonmammalian model ...
[33]
Vascular Growth Factors and Lymphangiogenesis
... lymph sacs originate by endothelial cell budding from embryonic veins. The ... venous connections (97). Although recent reports about the development ...
[34]
Cellular and molecular mediators of lymphangiogenesis in ...
Jun 10, 2021 · ... venous connections ... Segmental territories along the cardinal veins generate lymph sacs via a ballooning mechanism during embryonic ...
[35]
Definitive hematopoietic stem cells first develop within the major ...
The aorta–gonad–mesonephros (AGM) region is a potent hematopoietic site within the mammalian embryo body, and the first place from which hematopoietic stem ...Missing: 3rd pharyngeal pouch
[36]
Cardiovascular System - Blood Development - UNSW Embryology
Sep 28, 2020 · Blood formation occurs later (week 5) throughout embryoic mesenchyme, then liver, then spleen/thymus, bone marrow, lymph nodes.
[37]
Milroy disease and the VEGFR-3 mutation phenotype - PMC - NIH
This is a review of the condition based on the clinical findings in 71 subjects from 10 families. All 71 individuals have a mutation in VEGFR-3. Ninety per cent ...
[38]
Mutation in Vascular Endothelial Growth Factor-C, a Ligand for ...
Mar 15, 2013 · In conclusion, we have identified a VEGFC mutation that causes a Milroy-like primary lymphedema. Our findings demonstrate that mutations in ...
[39]
Age‐related thymic involution: Mechanisms and functional impact
Jul 12, 2022 · Age‐related thymic involution has many negative impacts on immune function including reduced pathogen resistance, high autoimmunity incidence, ...
[40]
Thymic involution and immune reconstitution - PMC - PubMed Central
Chronic thymus involution associated with aging results in less efficient T-cell development and decreased emigration of naïve T cells to the periphery.
[41]
Postnatal Involution and Counter-Involution of the Thymus - PMC
May 12, 2020 · Thymus involution occurs in all vertebrates. It is thought to impact on immune responses in the aged, and in other clinical circumstances such as bone marrow ...
[42]
The fetal-to-adult hematopoietic stem cell transition and its role ... - NIH
Fetal blood and immune cells gradually diminish during maturation of the infant and are almost completely replaced by adult types of cells by 3 to 4 weeks ...
[43]
Bone marrow niches for hematopoietic stem cells: life span ...
Jul 4, 2024 · From these, a functional subunit called the HSC niche provides lifelong support by promoting HSC quiescence, self-renewal, and niche retention.1 ...
[44]
The Hematopoietic Bone Marrow Niche Ecosystem - Frontiers
Current knowledge has revealed that upon chronic stimulation, BM remodeling is more extensive and otherwise quiescent HSCs may be lost due to diminished ...The Steady-State and Stress of... · The BM Niche in... · The Factors Supporting...Missing: lifelong | Show results with:lifelong
[45]
Lymphangiogenic factors, mechanisms, and applications - JCI
Signaling via VEGFC/D and VEGFR3 is perhaps the most central pathway for lymphangiogenesis (1, 6). VEGFC is essential for the sprouting of ECs from embryonic ...
[46]
Vascular Endothelial Growth Factor Receptor-3 in ... - PubMed Central
Our results suggest that transient lymphangiogenesis occurs in parallel with angiogenesis in healing wounds and that VEGFR-3 becomes up-regulated in blood ...
[47]
Mechanisms of Lymphatic Regeneration after Tissue Transfer
Our studies suggest that lymphatic regeneration after tissue transfer occurs by ingrowth of lymphatic vessels and spontaneous re-connection of existing ...
[48]
Exercise training improves obesity‐related lymphatic dysfunction
Aerobic exercise improves collecting lymphatic vessel pumping in obesity. Sedentary obese mice had a marked decrease (3.1‐fold) in collecting lymphatic vessel ...Missing: remodeling | Show results with:remodeling
[49]
The Lymphatic Vasculature: Its Role in Adipose Metabolism and ...
Oct 3, 2017 · Therefore, lymphatic malfunction due to obesity is reversible by behavioral modifications (diet and exercise).
[50]
Aging-Related Cellular, Structural and Functional Changes in the ...
The aging of lymph nodes results in decreased cell transport to and within the nodes, a disturbance in the structure and organization of nodal zones.
[51]
Pathophysiology of aged lymphatic vessels - Aging-US
Aug 28, 2019 · This aging-related alteration illustrates that the self-regulatory adjustment of lymphatic vessels is reduced to the changes in lymph flow [45].
[52]
Lymphatic Senescence: Current Updates and Perspectives - PMC
Apr 3, 2021 · We report that lymphatic senescence is associated with alterations in lymphatic muscles and nerve fibers, lymphatic endothelial cells membrane dysfunction.
[53]
Lymphatic System: Function, Conditions & Disorders
Each day, about 17 liters of plasma return to your bloodstream in this way. Since 20 liters initially flowed out of your capillary walls, that means 3 liters ...Missing: volume percentage
[54]
Increased intrinsic pumping of intestinal lymphatics following ...
The volume of lymph returned to the blood vascular system each day is ap- proximately 50 to 100% of the plasma volume. This lymph contains greater than 100 ...
[55]
Lymphatic System Flows - PMC - PubMed Central - NIH
Jan 1, 2019 · It is estimated (Renkin 1986) that capillaries lose to the interstitium some 8 L/day of fluid which becomes afferent lymph; after reabsorption ...
[56]
Contractile Physiology of Lymphatics - PMC - PubMed Central
The lymphatic system uses lymph pumps (extrinsic and intrinsic) to provide the energy necessary to overcome the steady state opposing pressure gradients and ...
[57]
Intrinsic pump-conduit behavior of lymphangions
Cyclical contractions of lymphangions usually actively pump lymph against a local pressure gradient. The concept that lymph is actively transported by lymphatic ...
[58]
Demonstration and Analysis of the Suction Effect for Pumping ...
Sep 21, 2017 · We provide definitive evidence for the existence of 'suction pressure' in collecting lymphatic vessels, which manifests as a transient drop in pressure ...Results · Evidence Of Suction In... · Negative Transmural Pressure...<|separator|>
[59]
Capillary fluid filtration. Starling forces and lymph flow.
Starling force analyses still provide the major means of assessing an organ's ability to regulate its interstitial volume, and several organ systems have not ...
[60]
A comprehensive review of the natural lymphaticovenous ...
Jan 19, 2016 · In this study they found evidence of LVC with a calculated amount of shunting of 6.6% of the total lymph flow in the contralateral blood sample ...
[61]
Physiology, Edema - StatPearls - NCBI Bookshelf
May 1, 2023 · Lymphatic obstruction can also lead to fluid buildup because, under normal conditions, filtered fluids do not return to the systemic circulation ...
[62]
Pathophysiology of Edema Formation - Capillary Fluid Exchange
Lymphedema arises in response to a variety of conditions that result in reduced lymph flow. When lymphatic outflow (JL) is completely occluded, interstitial ...
[63]
The Biogenesis of Chylomicrons - PMC - PubMed Central
Enterocytes convert these hydrolytic products rapidly back into water-insoluble TAG to avoid membrane disruption and package the TAG into a transport vehicle, ...
[64]
Regulation of Chylomicron Secretion: Focus on Post-Assembly ...
The majority of absorbed lipids are packaged into chylomicron (CM) particles in the intestinal enterocyte, secreted into and transported through the lymphatic ...
[65]
Lymphatic Anatomy and Physiology - PMC - PubMed Central - NIH
The lymphatic system functions as a diffuse network of vasculature that exchanges, transports, and reabsorbs a wide variety of molecules and cells.
[66]
The Intestinal Lymphatic System: Functions and Metabolic Implications
Dietary lipids are absorbed on the apical side of enterocytes. Once inside the lacteals, CMs are transported via the lymph through mesenteric lymph nodes and ...Vegf-A Regulates Cm Uptake... · Lymphatic Flow During Lipid... · Lymphatic Transport Of...
[67]
Postprandial lymphatic pump function after a high-fat meal
Dietary lipids are transported from the intestine through contractile lymphatics. Chronic lipid loads can adversely affect lymphatic function.
[68]
Chylothorax - StatPearls - NCBI Bookshelf - NIH
Jul 28, 2024 · Unlike any other body fluid, chylothorax is rich in long-chain fatty acids absorbed from the small intestine.
[69]
Lymphatic Migration of Immune Cells - PMC - NIH
Another important function of the lymphatic network is to facilitate immune cell migration and antigen transport from the periphery to draining lymph nodes.Introduction · Dendritic Cells · Figure 1
[70]
M Cells: Intelligent Engineering of Mucosal Immune Surveillance
Jul 2, 2019 · M cells are specialized intestinal epithelial cells that provide the main machinery for sampling luminal microbes for mucosal immune surveillance.The Basic M Cell And... · M Cell Microparticle Capture... · Organized Lymphoid Tissues...
[71]
Lymphatic System: An Active Pathway for Immune Protection - NIH
New findings suggest that the lymphatic system may control the ultimate immune response through a number of ways which include guiding antigen/dendritic cells ( ...
[72]
CC Chemokine Receptor 7–dependent and –independent ... - NIH
Cognate interaction of chemokine receptor CCR7 on lymphocytes with its ligands CCL19 and CCL21 expressed on high endothelial venules (HEVs) is essential for ...
[73]
High endothelial venules (HEVs) in immunity, inflammation and cancer
High endothelial venules (HEVs) are specialized blood vessels mediating lymphocyte trafficking to lymph nodes (LNs) and other secondary lymphoid organs.
[74]
The lymph node at a glance – how spatial organization optimizes ...
SCSMɸs are also important for the induction of adaptive immune responses in the LN. For example, SCSMɸs facilitate B cell priming by transferring antigens to B ...
[75]
The microanatomy of B cell activation - PMC - PubMed Central - NIH
Schematic of a lymph node showing the locations for antigen presentation to B cells. 1) Subcapsular region. 2) Lymphoid follicle. 3) T zone (paracortex) in the ...
[76]
The transcriptional program during germinal center reaction - PMC
The germinal center (GC) reaction is a key process during an adaptive immune response to T cell specific antigens. GCs are specialized structures within ...
[77]
T-Cell Tolerance: Central and Peripheral - PMC
Peripheral tolerance processes exist wherein self-reactive T cells become functionally unresponsive (anergy) or are deleted after encountering self-antigens ...
[78]
Lymph node stroma broaden the peripheral tolerance paradigm - PMC
We now know that lymph node stromal cells (LNSC) are important mediators of deletional tolerance to peripheral tissue-restricted antigens (PTAs).
[79]
Regulation of T-cell Tolerance by Lymphatic Endothelial Cells - PMC
Here, we describe how lymphatic endothelial cells induce peripheral T-cell tolerance and how this relates to tolerance induced by other types of antigen ...
[80]
Lymphatic Function and Immune Regulation in Health and Disease
In this review, we will summarize the current knowledge of how lymphatic function is altered in inflammatory states, cancer, and infection.Lymphatic Vessels · Lymph Nodes · Lymphatics In Inflammation
[81]
Lymph node dissection – understanding the immunological function ...
All lymphocytes, including naive or effector cells, migrate to the medulla to leave the LN via the efferent lymphatics or the blood system. Conversely, oral ...
[82]
MRI of the Central Lymphatic System: Indications, Imaging ...
We describe how MR lymphangiography can be used to diagnose central lymphatic system anatomy and pathology, which can be used for diagnostic purposes or for pre ...
[83]
Lymphoscintigraphy - StatPearls - NCBI Bookshelf - NIH
Lymphoscintigraphy is a nuclear medicine imaging technique for mapping the lymphatic system using radiopharmaceuticals or radiotracers.
[84]
Role of lymphoscintigraphy in diagnosis and management of ... - NIH
For functional evaluation of lymphatic channels, lymphoscintigraphy, is a widely available, simple imaging test, highly useful for documentation of lymphedema ...
[85]
Procedural Recommendations for Lymphoscintigraphy in the ... - NIH
Jan 7, 2019 · Dynamic lymphoscintigraphic evaluation measures variations in lymph obstruction in flow at the lymph nodes or lymphatic vessel displacement.
[86]
Nodal and Pedal MR Lymphangiography of the Central Lymphatic ...
The mainstay of lymphatic imaging today is magnetic resonance lymphangiography (MRL). It provides information on the anatomy of the central lymphatic system, ...
[87]
Lymphatic obstruction: MedlinePlus Medical Encyclopedia
Jan 1, 2025 · CT or MRI scan; Imaging tests to check the lymph nodes and lymph drainage (lymphangiography and lymphoscintigraphy). Treatment. Expand Section.
[88]
Intraoperative use of indocyanine green fluorescence imaging ... - NIH
Oct 14, 2021 · In that regard, ICG fluorescence has optimized the intraoperative vision of anatomical structures by the enhancement of blood and lymph flow.
[89]
Role of Indocyanine Green in Fluorescence Imaging with Near ...
Indocyanine green (ICG) is used in innovative surgical techniques, for example to stain organs and tumor tissue, for the intraoperative imaging of flap plasty ...
[90]
Sonography Vascular and Lymphatic Assessment, Protocols ... - NCBI
Jan 16, 2023 · This activity reviews the assessment, protocols, and interpretation of commonly encountered vascular and lymph node pathologies while reviewing common ...
[91]
Diagnostic Efficacy of Ultrasonography, Doppler ... - PubMed Central
Color Doppler US findings. On Doppler ultrasound examination, 55 (61.1%) lymph nodes showed central (hilar) blood supply, 28 (31.1%) showed peripheral blood ...
[92]
Doppler ultrasound examination of pathologically enlarged lymph ...
Many enlarged lymph nodes gave rise to significant Doppler-shift signals indicating increased blood flow. The signals have been spectrum analysed and the large ...Missing: assessment | Show results with:assessment
[93]
Nuclear Medicine PET/CT Lymphomas Assessment, Protocols, and ...
Aug 21, 2023 · This activity highlights the role of PET/CT in the management of lymphoma patients, which includes initial staging, monitoring the interim response of the ...
[94]
18F-FDG PET/CT Imaging In Oncology - PMC - PubMed Central
18 F-FDG PET/CT is more sensitive and specific in certain cancers and has been applied primarily as a staging and restaging tool that can guide patient care.
[95]
PSMA PET-CT Accurately Detects Prostate Cancer Spread - NCI
May 11, 2020 · PSMA PET-CT was more accurate for both metastases found in lymph nodes in the pelvis and in more distant parts of the body, including bone.
[96]
Lymphedema - StatPearls - NCBI Bookshelf
Apr 19, 2023 · Lymphedema is a chronic disease marked by the increased collection of lymphatic fluid in the body, causing swelling, which can lead to skin and tissue changes.
[97]
Milroy Disease - GeneReviews® - NCBI Bookshelf
Apr 27, 2006 · The prevalence of Milroy disease is not known but it appears to be one of the more common causes of primary lymphedema, occurring in all ethnic ...Diagnosis · Clinical Characteristics · Differential Diagnosis · Genetic Counseling
[98]
Meige Disease (Lymphedema Praecox) - Cleveland Clinic
Jan 13, 2025 · Lymphedema praecox is a genetic condition in which your lymphatic system doesn't develop normally in certain parts of your body. Without the ...
[99]
Primary Lymphedema: Update on Genetic Basis and Management
... primary lymphedema have sporadic disease with an unknown mutation. Genetic ... Milroy disease presents at birth and is caused by mutations in VEGFR3.Missing: embryonic | Show results with:embryonic
[100]
Lymphedema and Cancer - Side Effects - NCI
Mar 6, 2024 · Lymphoscintigraphy uses a small amount of radioactive glucose to allow doctors to trace the flow of lymph fluid and identify blockages.
[101]
Filariasis - StatPearls - NCBI Bookshelf - NIH
Sep 18, 2025 · Lymphatic filariasis, the most common form, is associated with Wuchereria bancrofti, Brugia malayi, or Brugia timori. Other forms include ...
[102]
Educational Review: Management of Lymphedema—Approaches ...
May 20, 2025 · CDT is often regarded as the first-line treatment for lymphedema, with studies revealing reduction in limb volumes and improvement in quality of ...
[103]
Surgical lymphedema treatment: 8 things to know
Jun 20, 2022 · Lymphovenous bypass surgery: surgeons “go around” blockages by rerouting functional lymphatic vessels into healthy blood vessels, allowing ...
[104]
Lymphedema - Symptoms and causes - Mayo Clinic
Nov 24, 2022 · Lymphedema refers to tissue swelling caused by an accumulation of protein-rich fluid that's usually drained through the body's lymphatic system.
[105]
Cat Scratch Disease - StatPearls - NCBI Bookshelf
Cat scratch disease (Cat scratch fever) causes a febrile illness with subacute regional lymphadenopathy. The agent of infection is Bartonella henselae.
[106]
Delineating the Boundaries of Superficial Lymphangitis
Aug 29, 2023 · Lymphangitis is an inflammation of lymphatic channels caused by infectious or non-infectious agents, presenting with characteristic linear erythematous streaks.
[107]
Mononucleosis - StatPearls - NCBI Bookshelf
Lymphoid hyperplasia is common and may be seen as generalized lymphadenopathy, tonsillitis, and hepatosplenomegaly.
[108]
THE LYMPH NODE IN HIV PATHOGENESIS - PMC - PubMed Central
An increasing body of evidence has implicated the lymphoid organs as central to the pathogenesis of immune deficiency in chronic HIV-1 infection.
[109]
About Toxoplasmosis - CDC
Mar 11, 2025 · Those with symptoms may experience flu-like symptoms, swollen lymph nodes, muscle aches, and pains.
[110]
Toxoplasmosis lymphadenopathy-A series of 8 cases diagnosed in ...
Immune response against Toxoplasma is triggered when the parasite enters the draining lymph nodes and are captured by subcapsular sinus macrophages.
[111]
MALT Lymphoma of Minor Salivary Glands in a Sjögren's Syndrome ...
Sjögren's syndrome patients have a 44-fold excess risk for the development of non-Hodgkin's lymphoma particularly mucosa-associated lymphoid tissue (MALT) ...
[112]
Tertiary lymphoid structures in autoimmune diseases - PMC
Jan 8, 2024 · While TLSs suggest a good prognosis in tumors, the opposite is true in autoimmune diseases. This review article will discuss the current views ...
[113]
Severe Combined Immunodeficiency - StatPearls - NCBI Bookshelf
In SCID, microscopic examination of the thymic stroma reveals an absence of lymphoid cells, as well as the absence of Hassall's corpuscles. In essence, the ...
[114]
DiGeorge Syndrome - StatPearls - NCBI Bookshelf
The degree of immunodeficiency of patients with DGS can present differently depending on the extent of thymic hypoplasia. Some patients may have a mild to ...Introduction · History and Physical · Evaluation · Treatment / Management
[115]
The lymphatic system throughout history: From hieroglyphic ...
Apr 5, 2022 · He named the transport of chyle to the liver and its further transportation into blood 'αναδοσις', which is chylification. Galen also addressed ...
[116]
The discovery of the lymphatic system in the seventeenth century ...
Gaspare Aselli discovered chyle vessels in a living well-fed dog in 1622. He introduced the term 'lacteals' or milky veins. According to Aselli, the lacteals ...
[117]
Rudolf Virchow - PMC - NIH
Virchow's greatest accomplishment was his observation that a whole organism does not get sick—only certain cells or groups of cells. In 1855, at the age of 34, ...Missing: lymph immunity
[118]
Fine structure of chicken thymic epithelial vesicles
Jan 1, 1976 · Thymic epithelial vesicles have been observed in the chicken with the light microscope (Hammar, 1905; Salkind, 1915; Hoffmann-Fezer, 1973), but ...
[119]
Lymphangiography; a technique for its clinical use in the lower limb
Lymphangiography; a technique for its clinical use in the lower limb. Br Med J. 1955 Apr 16;1(4919):940-2. doi: 10.1136/bmj.1.4919.940. Authors. J B KINMONTH ...Missing: 1950s pioneer
[120]
LYVE-1, a New Homologue of the CD44 Glycoprotein, Is a Lymph ...
Hence, LYVE-1 is the first lymph-specific HA receptor to be characterized and is a uniquely powerful marker for lymph vessels themselves. Keywords: hyaluronic ...Missing: discovery | Show results with:discovery
[121]
On the adjective lymphaticus - PubMed
The adjective lymphaticus meant in Latin "stricken with nymph-like anger, gripped by madness." Thomas Bartholin, discoverer of the lymphatic system, was the ...
[122]
Scholars and scientists in the history of the lymphatic system - PMC
Galen's ideas on the lymphatic system are reported mainly in De usu partium (book IV, chapter XIX) and Anatomicis administrationibus (books VI and XIII).
[123]
CHYLE Definition & Meaning - Merriam-Webster
Middle English chilum, chile, borrowed from Medieval Latin chylus, chilus, borrowed from Greek chȳlós "juice, sap, chyle," of uncertain origin.
[124]
THYMUS Definition & Meaning - Merriam-Webster
Oct 11, 2025 · Etymology. New Latin, from Greek thymos warty excrescence, thymus ; First Known Use. 1578, in the meaning defined above ; Time Traveler. The first ...
[125]
Spleen - Etymology, Origin & Meaning
... Greek splēn "the milt, spleen," from PIE *spelghn- "spleen, milt" (source also of Sanskrit plihan-, Avestan sperezan, Armenian p'aicaln, Latin lien, Old ...
[126]
Historical overview of lymphangiogenesis - ResearchGate
In 1902, Florence Sabin proposed that lymph sacs originated from endothelial cells budding from the cardinal vein, and in 1993, Karl Alitalo demonstrated that ...
[127]
Chronic Lymphocytic Leukemia History - Rare Disease Advisor
Jan 28, 2025 · In 1856, Virchow described 2 forms of chronic leukemia—splenic and lymphatic—which today are known as leukemia and lymphoma, respectively.2.
[128]
Epidemiology and Etiology of Leukemia and Lymphoma - PMC
Lymphomas are neoplasms of well-differentiated B and T lymphocytes, which typically present as malignant masses in lymphatic tissue. Leukemias are generally ...